The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allowance of Banknote Disinfection Patent

8 Apr 2021 07:00

RNS Number : 7496U
Spectra Systems Corporation
08 April 2021
 

Spectra Systems Corporation

 

Allowance of Banknote Disinfection Patent by the United States Patent and Trademark Office

 

Spectra Systems Corporation, a leading provider of advanced technology solutions for banknote and product authentication and gaming security, is pleased to announce that it has received a notice of allowance from the United States Patent and Trademark Office for its technology for disinfecting banknotes from SARS-2 and other biohazards. The patent is expected to be issued within 6 weeks. Additionally, patent applications have been filed in other regions worldwide.

 

The technology can disinfect five million notes in less than 2 hours and uses nitrogen obtained from the ambient air to create an oxygen-free atmosphere, along with heat, to deactivate SARS-2.

 

 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

 

"The Covid-19 pandemic has raised questions about the health safety of banknotes. Given that several new SARS-2 variants have been shown to be more virulent, it is likely that Covid-19 will become endemic. Central banks and Casinos that exchange cash with the public may conclude that a proactive approach rather than denial is the logical approach to maintaining the use of cash worldwide. Our newest product is designed specifically to address this situation effectively, and its patent was we understand allowed in record time"

 

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 

 

WH Ireland Limited

Chris Fielding (Managing Director, Corporate Finance) Tel: +44 (0) 20 7220 1650

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDSDXGDGBR
Date   Source Headline
4th Nov 20145:51 pmRNSHolding(s) in Company
20th Oct 20147:00 amRNSAGM Postponement
30th Sep 20147:00 amRNSInterim results
10th Sep 20149:42 amRNSTR-1: Notification of major interest in shares
1st Sep 20147:00 amRNSNotice of AGM
24th Jul 20147:00 amRNSPartnership with Cool Clean Technologies
22nd Jul 20147:00 amRNSContract wins
24th Jun 20148:15 amRNSPosting of Annual Report and Accounts
23rd Jun 20147:00 amRNSCentral Bank testing Spectra's Aeris technology
20th Jun 20147:00 amRNSSettlement of lawsuit and termination of agreement
12th Jun 20147:00 amRNSTesting of Soiled Banknote Technology
9th May 20147:00 amRNSTR-1: Notification of major interest in shares
30th Apr 20147:00 amRNSPreliminary Results
16th Apr 20143:46 pmRNSTR-1: Notification of major interest in shares
25th Mar 20147:01 amRNSTR-1: Notification of major interest in shares
3rd Mar 20147:00 amRNSCompletion of Acquisition of Inksure Technologies
4th Feb 20143:33 pmRNSTR-1: Notification of major interest in shares
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
2nd Oct 20137:00 amRNSAcquisition of Assets from InkSure Technologies
1st Oct 20137:00 amRNSResult of AGM
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
30th Jul 20137:00 amRNSLarge Order from Central Bank
28th Jun 20137:00 amRNSPosting of Annual Report
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.